BMYB34 tahvilleri
Aşağıda BRISTOLMYERSDRN şirket tahvillerinin listesi bulunmaktadır. Yatırımcılar genellikle piyasa dalgalanması zamanlarında artan istikrarları için bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol | Vade sonu getirisi % | Hacim | Fiyat % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
---|---|---|---|---|---|---|---|---|---|
7,55% | 0 | 56,40% | 2,55% | 2050-11-13 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 7,51% | 60 K | 79,78% | 5,00% | 2045-08-15 | 15,71 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,86% | 0 | 69,05% | 3,90% | 2062-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,82% | 0 | 70,42% | 3,70% | 2052-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,81% | 0 | 66,34% | 2,35% | 2040-11-13 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 6,73% | 100 K | 78,70% | 4,35% | 2047-11-15 | 13,57 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,65% | 202 K | 72,70% | 3,25% | 2042-08-01 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 6,59% | 10 K | 93,18% | 5,70% | 2040-10-15 | 2,3 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,53% | 477 K | 78,52% | 4,25% | 2049-10-26 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,46% | 0 | 76,54% | 3,55% | 2042-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,45% | 108 K | 80,69% | 4,35% | 2047-11-15 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,40% | 5 K | 82,83% | 4,55% | 2048-02-20 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,40% | 65 K | 90,24% | 5,25% | 2043-08-15 | 4,06 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,38% | 20 K | 84,86% | 4,63% | 2044-05-15 | 3,69 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,33% | 60 K | 107,09% | 6,88% | 2097-08-01 | 62,42 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
6,25% | 0 | 84,87% | 4,50% | 2044-03-01 | 341,52 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6,19% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,2 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,19% | 381 K | 86,32% | 4,63% | 2044-05-15 | 744,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,17% | 0 | 94,07% | 5,65% | 2064-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,10% | 0 | 94,28% | 5,55% | 2054-02-22 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,02% | 1,09 M | 93,32% | 5,25% | 2043-08-15 | 218,37 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,00% | 0 | 104,69% | 6,40% | 2063-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,94% | 810 K | 86,09% | 4,13% | 2039-06-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,92% | 135 K | 91,51% | 5,00% | 2045-08-15 | 741,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,91% | 0 | 103,57% | 6,25% | 2053-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,87% | 0 | 96,68% | 5,50% | 2044-02-22 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,59% | 0 | 100,95% | 5,70% | 2040-10-15 | 151,01 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,50% | 20 K | 104,74% | 6,13% | 2038-05-01 | 219,25 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,28% | 0 | 104,30% | 5,88% | 2036-11-15 | 279,22 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,21% | 0 | 99,91% | 5,20% | 2034-02-22 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,14% | 0 | 88,91% | 2,95% | 2032-03-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5,11% | 5 K | 96,29% | 3,45% | 2027-11-15 | 16,55 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 5,00% | 55 K | 97,30% | 3,90% | 2028-02-20 | 43,84 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
4,95% | 0 | 105,70% | 5,90% | 2033-11-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,87% | 6,17 M | 85,12% | 1,45% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,72% | 567 K | 99,78% | 3,88% | 2025-08-15 | 228,73 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,64% | 0 | 102,12% | 5,10% | 2031-02-22 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,60% | 750 K | 95,71% | 3,40% | 2029-07-26 | 26,56 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,59% | 0 | 100,28% | 4,95% | 2026-02-20 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,56% | 4,03 M | 95,88% | 3,40% | 2029-07-26 | 2,37 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,54% | 0 | 105,53% | 5,75% | 2031-02-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,50% | 50 K | 100,26% | 4,85% | 2026-02-20 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,36% | 0 | 98,15% | 3,25% | 2027-02-27 | 512,28 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,35% | 0 | 101,80% | 4,90% | 2029-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,32% | 13,37 M | 98,20% | 0,75% | 2025-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,26% | 13,15 M | 98,88% | 3,20% | 2026-06-15 | 1,74 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,25% | 0 | 92,89% | 1,13% | 2027-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,24% | 0 | 101,10% | 4,90% | 2027-02-22 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,17% | 115 K | 98,36% | 3,45% | 2027-11-15 | 517,67 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,17% | 141 K | 103,76% | 6,80% | 2026-11-15 | 255,95 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
4,15% | 215 K | 99,38% | 3,90% | 2028-02-20 | 1,45 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,69% | 0 | 85,84% | 1,75% | 2035-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. | |
3,43% | 0 | 99,96% | 1,00% | 2025-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. | |
2,47% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,39% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,35% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,32% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,27% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,95 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,47% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,28% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |